Oxford Cannabinoid Technologies (OCTP) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock OCTP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Oxford Cannabinoid Technologies Holdings PLC Price / BookDecember 28, 2024 | investing.comSnoop Dogg-Backed Cannabis Biotech Joins Forces With Former Google Experts To Boost AI Drug DiscoveryNovember 6, 2024 | benzinga.comOxford Cann Share ChatMay 24, 2024 | lse.co.ukOxford Cannabinoid to Delist from London Stock ExchangeMay 8, 2024 | marketwatch.comA bad trip: Oxford Cannabinoid to delist from ‘turbulent’ London marketsMay 8, 2024 | msn.comOxford Cannabinoid Technologies Holdings PLCOctober 15, 2023 | wsj.comWeed In Europe: Medical Marijuana In Ukraine, Albania's Hemp, UK Cannabis Study Lacks DiversityOctober 12, 2023 | benzinga.comOxford Cannabinoid Technologies CEO says objective "absolutely met" in lead asset trialOctober 10, 2023 | finance.yahoo.comOxford Cannabinoid readies for next stage as it safely navigates phase I stduyOctober 10, 2023 | proactiveinvestors.comOxford Cannabinoid readies for next stage as it safely navigates phase I studyOctober 10, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies reports no adverse events in OCT461201 trialSeptember 25, 2023 | finance.yahoo.comOxford Cannabinoid Technologies in a "comfortable position" ahead of Phase 1 results releaseSeptember 1, 2023 | finance.yahoo.comOxford Cannabinoid Technologies hails defining year as...Oxford Cannabinoid Technologies hails defining year as clinical...August 31, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies "officially on the way" after first dosingJuly 28, 2023 | finance.yahoo.comOxford Cannabinoid Technologies takes pain drug into phase I; appoints leading pain expertJuly 27, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies announces "potential breakthrough" in field of oncologyJuly 24, 2023 | finance.yahoo.comOxford Cannabinoid appoints chief medical officerJune 8, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies reaches milestone with phase 1 trial approval for pain relief drugMay 18, 2023 | proactiveinvestors.comOxford Cannabinoid rise continues as first clincial trial gets startedMay 17, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies confirms CEO appointment, licence renewal and clinical progressApril 13, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies confirms Sowemimo-Coker as permanent CEOApril 12, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies shares spike on CEO appointment and licence renewalApril 12, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies Holdings Plc (OCTP.L)March 1, 2023 | finance.yahoo.comOxford Cannabinoid Technologies Holdings PLC (OCTP)February 10, 2023 | uk.investing.comOxford Cannabinoid interim loss nearly doubles as research costs surgeJanuary 25, 2023 | lse.co.ukProactive's John Savin publishes fresh research note on Oxford Cannabinoid TechnologiesJanuary 24, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies with "lots to look forward to" after interimsJanuary 23, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies "proceeding forward as planned" after review meetingJanuary 12, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies "ready to go" after phase 1 trial submissionJanuary 6, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies hails 'milestone' as it submits Phase I trial application for lead programmeJanuary 5, 2023 | proactiveinvestors.comOxford Cannabinoid Technologies nearly ready for new phase 1 trialNovember 14, 2022 | proactiveinvestors.comData from pre-clinical study of OCT461201 shows positive resultsNovember 14, 2022 | finance.yahoo.com Get Oxford Cannabinoid Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OCTP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OCTP Media Mentions By Week OCTP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCTP News Sentiment▼0.000.72▲Average Medical News Sentiment OCTP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCTP Articles This Week▼00▲OCTP Articles Average Week Get the Latest News and Ratings for OCTP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oxford Cannabinoid Technologies and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ValiRx News Roquefort Therapeutics News Oncimmune News Oxford Nanopore Technologies News Genus News Oxford Biomedica News PureTech Health News Avacta Group News Faron Pharmaceuticals Oy News 4basebio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OCTP) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Cannabinoid Technologies Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Cannabinoid Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OCTP Stock Alerts